Astra's vaccine has been approved for use in Europe as a 3rd booster shot.

Astra's vaccine has been approved for use in Europe as a 3rd booster shot. - Printable Version

+- Bonjour Dewi BB (http://www.bonjourdewi.com/bb)
+-- Forum: My Category (http://www.bonjourdewi.com/bb/forumdisplay.php?fid=1)
+--- Forum: My Forum (http://www.bonjourdewi.com/bb/forumdisplay.php?fid=2)
+--- Thread: Astra's vaccine has been approved for use in Europe as a 3rd booster shot. (/showthread.php?tid=199)

Pages: 1 2 3 4

Astra's vaccine has been approved for use in Europe as a 3rd booster shot. - ji2222 - 08-29-2022

[Image: 45c9a4a1e0f6fa25463c3aa3fc2b57cf.jpg]

Vaccines against COVID-19 of AstraZeneca It isSLOTXOgame, big lion slot, low bet, easy to play, outstanding and unique with the use of Avalanche / Cascading wins system, FreeSpins, FreeSpins Multiplier, Gamble, Megaways, Risk/Gamble (Double) game, Scatter symbols is another slot game. That has received reviews from around the world that it's easy to play, fun, tight quality. approved for use as a third booster vaccine in the European Union.

The approval comes after a recommendation by the European Union's Human Medicines Review Board. in the approval of the vaccine against COVID-19 AstraZeneca's third booster vaccine is available to people who have received the first two doses of the COVID-19 vaccine. of AstraZeneca or mRNA vaccine approved by the European Union.

Vaccines against COVID-19 of AstraZeneca It has been approved by the European Medicines and Healthcare Products Regulatory Agency (EMA) for use as a third booster vaccine in adults.

Healthcare workers can now use the vaccine against COVID-19. AstraZeneca's third booster vaccine is available to people who have received the first two doses of the COVID-19 vaccine. of AstraZeneca or mRNA vaccine approved by the European Union.

this approval It was reviewed by the European Union's Committee on Medicines for Human Use (CHMP) with data backed by numerous studies indicating an increased level of immunity after vaccination against COVID-19. AstraZeneca's vaccine is the third booster after the first two doses of AstraZeneca or the mRNA1-5 vaccine.

Although more than 65% of the world's population has been vaccinated against COVID-19. then at least one needle 6 But increasing the population to receive both full doses of vaccine and receive a third booster dose remains a major challenge for now. After this approval, healthcare professionals will have more options to recommend vaccines to people.

Sir Mene Pangalos, Executive Vice President of Research and Development for Biopharmaceuticals AstraZeneca's Biopharmaceuticals said: "Approval for a vaccine against COVID-19 AstraZeneca's ability to use as a third booster vaccine is an important step towards our goal of preventing COVID-19. for people around the world Long-term protection of the immune system is essential for long-term control and management of the disease. This booster will help boost the immune system that decreases over time after the first two doses of vaccination.”

There are many studies that support the COVID-19 vaccine. of AstraZeneca as a third booster vaccine After receiving the first two doses of different types of vaccines, including the COVID-19 vaccine of AstraZeneca, mRNA vaccine and CoronaVac1,7-12 vaccine.

Vaccines against COVID-19 of AstraZeneca It is approved for use as a third booster dose after the same vaccination. (Those who received the first two doses of vaccine against COVID-19 of AstraZeneca) in the UK and many other countries in Asia and Latin America It has also been approved for use as a third booster dose after heterogeneous vaccination. (Those who received the first two doses of the viral vector vaccine other than the COVID-19 vaccine of AstraZeneca or inactivated vaccines or mRNA vaccines) in many countries outside the European Union.

Based on data from a simulated study evaluating the global impact of COVID-1913, AstraZeneca's vaccine has prevented more than 50 million infections of the COVID-19 virus, preventing illness. from COVID-19 to a level that required more than 5 million hospitalizations and has helped protect more than 1 million lives from COVID-1913.

Vaccines against COVID-19 of AstraZeneca
Vaccines against COVID-19 of AstraZeneca (ChAdOx1-S [Recombinant]) invented by the University of Oxford. The vaccine was developed by inserting a portion of the genetic material used to decode the cell surface protein thorn formation of the coronavirus SARS-CoV-2 in a scaffold of an adenovirus that causes the common cold in chimpanzees that have been infected. weakened and unable to divide After vaccination, human cells respond by producing proteins similar to the cellular surface protein of the coronavirus SARS-CoV-2, which in turn encourages the body to build up immunity to fight SARS-CoV-. 2 In the event that the virus enters the body later